American International Group, Inc. Tango Therapeutics, Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$7.51 - $12.88 $1,419 - $2,434	-189 Reduced 0.85%	22,001 $174,000
Q4 2023 Feb 13, 2024	SELL	$6.52 - $12.01 $580 - $1,068	-89 Reduced 0.4%	22,190 $219,000
Q3 2023 Nov 13, 2023	BUY	$2.93 - $11.26 $2,320 - $8,917	792 Added 3.69%	22,279 $250,000
Q2 2023 Aug 04, 2023	SELL	$2.67 - $4.7 $2,723 - $4,794	-1,020 Reduced 4.53%	21,487 $71,000
Q1 2023 May 12, 2023	BUY	$3.76 - $8.06 $1,680 - $3,602	447 Added 2.03%	22,507 $88,000
Q4 2022 Feb 10, 2023	SELL	$3.41 - $8.29 $276 - $671	-81 Reduced 0.37%	22,060 $159,000
Q3 2022 Nov 14, 2022	BUY	$3.25 - $5.46 $1,017 - $1,708	313 Added 1.43%	22,141 $80,000
Q2 2022 Aug 12, 2022	BUY	$3.86 - $8.01 $84,256 - $174,842	21,828 New	21,828 $99,000

123

91.7M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $345M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.